MarketPeel
Insider Trading Intelligence
Pricing
…
JM

Johanna Mercier

GILD
CHIEF COMMERCIAL OFFICER · GILEAD SCIENCES, INC. · CIK 0001782135
FILING MIX · LIFETIME41%/59%
BUYS
69
SELLS
101
TOTAL VALUE
$50.12M
COMPANIES
2
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
128,321
AVG SELL PX
$104.47
TRADE KIND
SHOWING 170 / 170
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
24 backtested trades · 8 horizons · 38 pending
Forward-return performance of every backtestable P/S trade by Johanna Mercier, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d24+45.83%-0.39%+0.70%-1.09%-1.09%—
14d24+50.00%-0.86%+1.15%-2.01%-2.82%—
30d24+50.00%-0.91%+1.76%-2.67%-2.71%—
60d24+20.83%+2.12%+4.77%-2.65%-2.83%—
90d24+16.67%+6.03%+6.64%-0.60%+1.56%—
180d24(3 pending)+4.76%+20.47%+8.28%+12.19%+16.18%—
1y24(13 pending)+9.09%+27.06%+20.61%+6.45%-5.05%—
2y24(22 pending)+0.00%+34.59%+24.13%+10.46%+10.46%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GILD · 125,754 shares · as of Jun 15, 2026
042,91885,835128,753171,670202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 69 buys / 101 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
1,480$123.42$182.7K125,754Jun 15, 2026Jun 16, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
450$125.40$56.4K124,234Jun 15, 2026Jun 16, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
1,070$124.00$132.7K124,684Jun 15, 2026Jun 16, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Comm & Corp Aff Officer
2,796——128,575Jun 10, 2026Jun 11, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Comm & Corp Aff Officer
1,341$121.48$162.9K127,234Jun 10, 2026Jun 11, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Comm & Corp Aff Officer
2,796——27,851Jun 10, 2026Jun 11, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
2,567——2,567May 27, 2026May 29, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
3,318——6,853May 21, 2026May 21, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
3,318——0May 21, 2026May 21, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Comm & Corp Aff Officer
25,000——23,110May 15, 2026May 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
700$132.75$92.9K125,779May 15, 2026May 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
11,177$131.19$1.47M134,853May 15, 2026May 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
8,374$132.23$1.11M126,479May 15, 2026May 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
7,749$130.29$1.01M146,030May 15, 2026May 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Comm & Corp Aff Officer
25,000$66.64$1.67M153,779May 15, 2026May 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$140.96$422.9K128,779Apr 15, 2026Apr 16, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$144.23$432.7K131,779Mar 16, 2026Mar 17, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Comm & Corp Aff Officer
6,617——21,057Mar 10, 2026Mar 12, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Comm & Corp Aff Officer
3,216$148.56$477.8K134,779Mar 10, 2026Mar 12, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Comm & Corp Aff Officer
6,617——137,995Mar 10, 2026Mar 12, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
35,880——35,880Mar 10, 2026Mar 12, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
9,590——30,647Mar 10, 2026Mar 12, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
11,090——131,378Feb 27, 2026Mar 2, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
9,395$154.91$1.46M120,488Feb 17, 2026Feb 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Comm & Corp Aff Officer
25,000$66.64$1.67M148,288Feb 17, 2026Feb 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
18,405$154.18$2.84M129,883Feb 17, 2026Feb 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
200$155.62$31.1K120,288Feb 17, 2026Feb 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Comm & Corp Aff Officer
25,000——48,110Feb 17, 2026Feb 18, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
44,867——148,088Feb 3, 2026Feb 5, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Comm & Corp Aff Officer
24,800$143.28$3.55M123,288Feb 3, 2026Feb 5, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$124.31$372.9K103,221Jan 15, 2026Jan 16, 2026 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$122.00$366.0K106,221Dec 15, 2025Dec 16, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,842——27,674Dec 10, 2025Dec 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,814$121.34$220.1K109,221Dec 10, 2025Dec 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,842——111,035Dec 10, 2025Dec 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
25,524$125.83$3.21M109,669Nov 17, 2025Nov 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
25,000$66.64$1.67M135,193Nov 17, 2025Nov 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
2,476$126.26$312.6K107,193Nov 17, 2025Nov 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
25,000——73,110Nov 17, 2025Nov 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$118.08$354.2K110,193Oct 15, 2025Oct 16, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$113.57$340.7K113,193Sep 15, 2025Sep 16, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,819$115.25$209.6K116,193Sep 10, 2025Sep 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,844——31,516Sep 10, 2025Sep 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,844——118,012Sep 10, 2025Sep 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
11,800——98,810Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
11,800$118.50$1.40M117,168Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
2,800$118.51$331.8K114,368Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
700$118.97$83.3K117,168Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
11,800——111,310Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
700$66.64$46.6K117,868Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
200$118.97$23.8K114,168Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
700——110,610Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
11,800$66.64$786.4K128,968Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
11,800$118.51$1.40M117,168Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
700——98,110Aug 15, 2025Aug 18, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$111.03$333.1K117,168Jul 15, 2025Jul 16, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$110.17$330.5K120,168Jun 16, 2025Jun 17, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,843——124,995Jun 10, 2025Jun 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,827$110.09$201.1K123,168Jun 10, 2025Jun 11, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,843——35,360Jun 10, 2025Jun 11, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
1,435——0May 22, 2025May 22, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
1,435——3,535May 22, 2025May 22, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
12,500$107.52$1.34M124,152May 22, 2025May 23, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
3,000$107.52$322.6K121,152May 22, 2025May 23, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
12,500——135,610May 22, 2025May 23, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
12,500$66.64$833.0K136,652May 22, 2025May 23, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
12,500——123,110May 22, 2025May 23, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
12,500$107.52$1.34M124,152May 22, 2025May 23, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
3,318——3,318May 21, 2025May 22, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
11,090——39,203Mar 10, 2025Mar 12, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
49,020——49,020Mar 10, 2025Mar 12, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
8,080——28,113Mar 10, 2025Mar 12, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
8,080——128,059Mar 10, 2025Mar 12, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,907$117.21$457.9K124,152Mar 10, 2025Mar 12, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
19,793——94,933Feb 4, 2025Feb 6, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
70,712——165,645Feb 4, 2025Feb 6, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
45,666$97.99$4.47M119,979Feb 4, 2025Feb 6, 2025 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,752——76,879Dec 10, 2024Dec 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,739$92.34$160.6K75,140Dec 10, 2024Dec 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,752——36,193Dec 10, 2024Dec 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
5,000$91.28$456.4K73,127Nov 6, 2024Nov 7, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
13,432$83.25$1.12M78,127Sep 12, 2024Sep 13, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
15,925$84.23$1.34M91,559Sep 12, 2024Sep 13, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,734$81.44$141.2K107,484Sep 10, 2024Sep 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,752——39,945Sep 10, 2024Sep 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,752——109,218Sep 10, 2024Sep 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
9,513$78.03$742.3K105,466Aug 28, 2024Aug 29, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
5,490$73.98$406.2K114,979Aug 13, 2024Aug 14, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,714$65.25$111.8K120,469Jun 10, 2024Jun 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,751——122,183Jun 10, 2024Jun 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,751——43,697Jun 10, 2024Jun 11, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
2,982——2,982May 22, 2024May 23, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
1,435——1,435May 22, 2024May 23, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
2,100——2,100May 17, 2024May 21, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
2,100——0May 17, 2024May 21, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,025——116,172Mar 10, 2024Mar 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,025——36,962Mar 10, 2024Mar 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
17,305——47,448Mar 10, 2024Mar 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
87,970——87,970Mar 10, 2024Mar 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
4,559$75.12$342.5K118,432Mar 10, 2024Mar 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
6,819——122,991Mar 10, 2024Mar 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
6,819——30,143Mar 10, 2024Mar 11, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
20,086——81,687Jan 31, 2024Feb 2, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
53,969——135,656Jan 31, 2024Feb 2, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
22,509$78.26$1.76M113,147Jan 31, 2024Feb 2, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
8,242$85.23$702.5K82,729Jan 9, 2024Jan 10, 2024 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
2,730——39,987Dec 10, 2023Dec 11, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,247$79.02$98.5K90,971Dec 10, 2023Dec 11, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
2,730——92,218Dec 10, 2023Dec 11, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
2,730——42,717Sep 10, 2023Sep 11, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,256$76.00$95.5K89,488Sep 10, 2023Sep 11, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
2,730——90,744Sep 10, 2023Sep 11, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,174$77.66$246.5K48,326Jul 24, 2023Jul 25, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
7,505——51,500Jul 24, 2023Jul 25, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
7,505——45,447Jul 24, 2023Jul 25, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
2,730——45,267Jun 10, 2023Jun 12, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
2,730——52,952Jun 10, 2023Jun 12, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,272$78.12$99.4K43,995Jun 10, 2023Jun 12, 2023 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
4,290——4,290May 17, 2023May 19, 2023 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
2,100——2,100May 17, 2023May 19, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
16,350——55,682Mar 10, 2023Mar 13, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
74,565——74,565Mar 10, 2023Mar 13, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,025——47,283Mar 10, 2023Mar 13, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
7,951——39,332Mar 10, 2023Mar 13, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
5,116$79.50$406.7K82,225Mar 10, 2023Mar 13, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
7,951——87,341Mar 10, 2023Mar 13, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,025——79,390Mar 10, 2023Mar 13, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
15,325$84.02$1.29M76,365Jan 24, 2023Jan 26, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
38,270——91,690Jan 24, 2023Jan 26, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
29,124——53,420Jan 24, 2023Jan 26, 2023 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
463$87.97$40.7K40,430Dec 10, 2022Dec 13, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
990——40,893Dec 10, 2022Dec 13, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
990——50,308Dec 10, 2022Dec 13, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
990——40,361Sep 10, 2022Sep 12, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
458$65.28$29.9K39,903Sep 10, 2022Sep 12, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
990——51,298Sep 10, 2022Sep 12, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,206$60.80$194.9K39,371Jul 24, 2022Jul 26, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
7,505——42,577Jul 24, 2022Jul 26, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
7,505——52,288Jul 24, 2022Jul 26, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
990——59,793Jun 10, 2022Jun 13, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
462$60.74$28.1K35,072Jun 10, 2022Jun 13, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
990——35,534Jun 10, 2022Jun 13, 2022 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
9,724——9,724May 18, 2022May 20, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
171,670——171,670Mar 10, 2022Mar 14, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,962——32,943Mar 10, 2022Mar 14, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,025——33,803Mar 10, 2022Mar 14, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
27,840——60,783Mar 10, 2022Mar 14, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,025——36,905Mar 10, 2022Mar 14, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,221$57.92$186.6K34,544Mar 10, 2022Mar 14, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,962——37,765Mar 10, 2022Mar 14, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
18,630——30,778Jan 26, 2022Jan 28, 2022 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
7,505——15,573Jul 24, 2021Jul 27, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
7,505——39,930Jul 24, 2021Jul 27, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,425$69.02$236.4K12,148Jul 24, 2021Jul 27, 2021 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
8,833——8,833May 19, 2021May 20, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
19,496$66.09$1.29M8,068May 4, 2021May 5, 2021 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
17,180——17,180Apr 15, 2021Apr 16, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,025——31,590Mar 10, 2021Mar 12, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
15,845——47,435Mar 10, 2021Mar 12, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
3,025——28,999Mar 10, 2021Mar 12, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
92,205——92,205Mar 10, 2021Mar 12, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
1,435$63.91$91.7K27,564Mar 10, 2021Mar 12, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
8,068——25,974Jan 26, 2021Jan 28, 2021 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
12,282$58.83$722.6K17,906Nov 3, 2020Nov 5, 2020 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
26,270——30,188Nov 3, 2020Nov 5, 2020 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
3,587$73.64$264.1K3,918Jul 24, 2020Jul 28, 2020 ↗View →
GILD
GILEAD SCIENCES, INC.
SALE
Chief Commercial Officer
7,505——34,615Jul 24, 2020Jul 28, 2020 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
Chief Commercial Officer
7,505——7,505Jul 24, 2020Jul 28, 2020 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
71,850——71,850Mar 10, 2020Mar 12, 2020 ↗View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
12,100——42,120Mar 10, 2020Mar 12, 2020 ↗View →
Other insiders · GILD
Loading peer insiders…
About this filer
CIK 0001782135
ROLE
Chief Commercial Officer
PRIMARY
GILD
COMPANIES
2
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001782135DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback